Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001927

CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001927 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-927 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-927 Supplier MilliporeSigma Supelco Supplier No. R0231ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.
TRUSTED_SUSTAINABILITY

Specifications

CAS 75-05-8, 106308-44-5
Linear Formula C10H8F2N4O
UN Number UN 1648 3 / PGII
Concentration 1.0 mg/mL in acetonitrile:water (9:1)
Formula Weight 238.19
Packaging Ampule
Quantity 1 mL
Flash Point 2°C (35.6°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.